Study to Evaluate the Safety and Efficacy of the Renal Assist Device in Patients With Acute Renal Failure
A Multi-Center, Randomized, Controlled, Double-Blind, Phase II Study To Assess Safety and Efficacy With the Renal Assist Device (RAD) in Patients With Acute Renal Failure
Sponsor: RenaMed Biologics
Terminated
This trial was terminated. No reason was provided.
Other Kidney Failure, Acute trials with similar outcome
A PHASE2 clinical study on Kidney Failure, Acute, this trial is terminated or withdrawn. The trial is conducted by RenaMed Biologics and has accumulated 6 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE2
First recorded
Jan 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- RenaMed Biologics
For direct contact, visit the study record on ClinicalTrials.gov .